Skip to main content
SpringerLink
Log in

Pharmacokinetics of Digitoxin

  • Chapter
Cardiac Glycosides

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 56 / 2))

Abstract

Digitoxin is the main cardioactive glycoside in Digitalis purpurea and was purified by Nativelle (1864). Although it was the first cardiac glycoside introduced into clinical medicine, our knowledge of its pharmacokinetics and metabolism originates from research done during the last decades.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Amlie, J.P., Storstein, L., Heldaas, O.: Correlation between pharmacokinetics and inotropic and electrophysiologic response to digitoxin in the intact dog. J. Cardiovasc. Pharmacol. 1, 529–540 (1979)

    PubMed  CAS  Google Scholar 

  • Ashley, J.J., Brown, B.T., Okita, G.T., Wright, S.E.: The metabolites of cardiac glycosides in human urine. J. Biol. Chem. 232, 315–322 (1958)

    PubMed  CAS  Google Scholar 

  • Beerman, B., Hellström, K., Rosen, A.: Fate of orally administered 3H-digitoxin in man with special reference to absorption. Circulation 43, 852–862 (1971)

    Google Scholar 

  • Beerman, B., Hellström, K.: The efficacy of lymph drainage in the elimination of orally administered digitoxin and digoxin. Pharmacology 6, 17–21 (1971)

    Google Scholar 

  • Beller, G.A., Smith, T.W., Abelmann, W.H., Haber, E., Hood, W.B., Jr.: Digitalis intoxication. A prospective clinical study with serum level correlations. N. Engl. J. Med. 284, 989–997 (1971)

    PubMed  CAS  Google Scholar 

  • Benthe, H.F.: Organverteilung verschiedener Herzglykoside. In: Digitalistherapie, Beiträge zur Pharmakologie. Jahrmärker, H. (ed.), pp. 25–34. Berlin, Heidelberg, New York: Springer 1975

    Google Scholar 

  • Bentley, J.D., Burnett, G.H., Conklin, R.L., Wassenburger, R.H.: Clinical application of serum digitoxin levels. A simplified plasma determination. Circulation 41, 67–75 (1970)

    PubMed  CAS  Google Scholar 

  • Bever, R.J. Van, Duchateau, A.M.J.A., Pluym, B.F.M., Merkus, F.W.H.M.: The effect of colestipol on digitoxin plasma levels. Arzneim. Forsch. 26, 1891–1893 (1976)

    Google Scholar 

  • Bodem, G., Unruh, E. v.: Dihydrodigitoxin, a metabolite of digitoxin in humans. In: Cardiac glycosides, International Boehringer Mannheim Symposia. Bodem, G., Dengler, H.J. (eds.), part 1, pp. 74–84. Berlin, Heidelberg, New York: Springer 1978

    Google Scholar 

  • Brown, B.T., Ranger, D., Wright, S.E.: The excretory products of lanatoside C and digitoxin in the rat. J. Pharmacol. Exp. Ther. 113, 353–358 (1955)

    PubMed  CAS  Google Scholar 

  • Caldwell, J.H., Bush, C.A., Greenberger, N.J.: Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man. J. Clin. Invest. 50, 2638–2644 (1971)

    PubMed  CAS  Google Scholar 

  • Castle, M.C., Lage, G.L.: Metabolism and distribution of digitoxin in the rat. Arch. Int. Pharmacodyn. Ther. 203, 323–334 (1973)

    PubMed  CAS  Google Scholar 

  • Castle, M.C., Lage, G.L.: Cleavage by ß-glucuronidase of the water-soluble metabolites of digitoxin excreted in the bile of control and spironolactone-pretreated rats. Toxicol. Appl. Pharmacol. 27, 641–647 (1974)

    PubMed  CAS  Google Scholar 

  • Clark, D.R., Kalman, S.M.: Dihydrodigoxin: a common metabolite of digoxin in man. J. Pharmacol. Exp. Ther. 2, 148–150 (1974)

    CAS  Google Scholar 

  • Croxson, M.S., Ibbertson, H.K.: Serum digoxin in patients with thyroid disease. Brit. Med. J. 1975 III, 566–568

    Google Scholar 

  • Doherty, J.E., Perkins, W.H.: Digoxin metabolism in hypo-and hyperthyroidism. Studies with tritiated digoxin in thyroid disease. Ann. Int. Med. 64, 489–507 (1966)

    PubMed  CAS  Google Scholar 

  • Domschke, W., Meinecke, O., Domagk, G.F.: Untersuchungen zum Stoffwechsel des Digitaliszuckers Digitoxose in der Ratte. Naunyn Schmiedebergs Arch. Pharmacol. 265, 149–155 (1969)

    CAS  Google Scholar 

  • Dutta, S., Marks, B.H.: Species and ionic influences on the accumulation of digitalis glycosides by isolated perfused hearts. Brit. J. Pharmacol. 46, 401–408 (1972)

    CAS  Google Scholar 

  • Eickenbusch, W., Lahrtz, H.G., Seppelt, U., Zwieten, P.A. van: Serum concentration and urinary excretion of 3H-ouabain and 3H-digitoxin in patients suffering from hyperthyroidism or hypothyroidism. Klin. Wochenschr. 5, 270–275 (1970)

    Google Scholar 

  • Finkelstein, F.O., Goeffinet, J.A., Hendler, E.D., Lindenbaum, J.: Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis. Am. J. Med. 58, 525–531 (1975)

    PubMed  CAS  Google Scholar 

  • Fischer, C.S., Sjoerdsma, A., Johnson, R.: The tissue distribution and excretion of radioactive digitoxin. Circulation 5, 496–503 (1952)

    PubMed  CAS  Google Scholar 

  • Flasch, H., Heinz, N.: Konzentration von Herzglykosiden im Myokard und im Gehirn. Arzneim. Forsch. 26, 1213–1216 (1976)

    CAS  Google Scholar 

  • Flasch, H., Heinz, N., Petersen, R.: Affinität von polaren Digoxin-und Digitoxin-Metabo- liten zu Digoxin-und Digitoxin-Antikörpern. Arzneim. Forsch. 27, 649–653 (1977)

    CAS  Google Scholar 

  • Forester, W., Lewis, R.P., Weissler, A.M., Wilke, T.A.: The onset and magnitude of the contractile response to commonly used glycosides in normal subjects. Circulation 49, 517–521 (1974)

    PubMed  CAS  Google Scholar 

  • Friedman, M., St. George, S., Bine, R., Jr.: The behavior and fate of digitoxin in the experimental animal and man. Medicine 33, 15–41 (1954)

    PubMed  CAS  Google Scholar 

  • Förster, W., Gadke, K.: The uptake and content of digitoxin and its metabolites in the heart muscle in guinea-pigs after acute and chronic application. Biochem. Pharmacol. 16, 1165–1174 (1957)

    Google Scholar 

  • Gade, J., Zwieten, P.A. van: Vergleichende Untersuchungen am Meerschweinchen über die Serumradioaktivität, die Ausscheidung und die Gewebsverteilung von 3H-Digitoxigenin. Naunyn Schmiedebergs Arch. Pharmacol. 264, 234–235 (1969)

    Google Scholar 

  • Giardina, A.C.V., Ehlers, K.H., Morrison, J.B., Engle, M.A.: Serum digitoxin concentrations in infants and children. Circulation 51, 713–717 (1975)

    PubMed  CAS  Google Scholar 

  • Gilfrich, H.J.: Untersuchungen zur Pharmakokinetik von Digoxin bei hyperthyreoten Patienten. Verh. Dtsch. Ges. Inn. Med. 82, 1726–1728 (1976)

    PubMed  Google Scholar 

  • Gjerdrum, K.: Digitoxin studies. Acta Med. Scand. 191, 25–35 (1972)

    PubMed  CAS  Google Scholar 

  • Greeff, K., Hafner, D., Strobach, H., Wirth, K.E.: Vergleich der biologischen Verfügbarkeit und renalen Elimination von Digitoxin und Digoxin. Herz/Kreisl. 11, 221–224 (1979)

    CAS  Google Scholar 

  • Greenberger, N.J., Thomas, F.B.: Biliary excretion of 3H-digitoxin: Modification by bile salts and phenobarbital. J. Lab. Clin. Med. 80, 241–251 (1973)

    Google Scholar 

  • Griffin, C.L., Pendleton, R., Burstein, S.: Metabolism of cardiac glycosides-II. Cardiotoxicity of metabolites of digitoxin-7. Biochem. Pharmacol. 20, 97–102 (1971)

    PubMed  Google Scholar 

  • Herrmann, I., Repke, K.: Über das Glukuronsäurekonjugat eines Cardenolidgenins β-Epidigitoxigenin). Experientia 19, 472–474 (1963)

    PubMed  CAS  Google Scholar 

  • Herrmann, I., Repke, K.: Entgiftungsgeschwindigkeit und Kumulation von Digitoxin bei verschiedenen Species. Naunyn-Schmiedebergs Arch. Pharmacol. 247,19–34 (1964a)

    CAS  Google Scholar 

  • Herrmann, I., Repke, K.: Speciesunterschiede in der Biotransformation von Digitoxin. Naunyn-Schmiedebergs Arch. Pharmacol. 247,35–48 (1964b)

    CAS  Google Scholar 

  • Herrmann, I., Repke, K.: Konjugation von Cardenolidgeninen mit Schwefelsäure oder Glucuronsäure. Naunyn-Schmiedebergs Arch. Pharmacol. 248, 370–386 (1964c)

    CAS  Google Scholar 

  • Herrmann, I., Repke, K.: Epimerisierung und Hydroxylierung von digitaloiden Steroidlactonen durch Fermente der Leber. Naunyn-Schmiedebergs Arch. Pharmacol. 248, 351–369 (1964)

    CAS  Google Scholar 

  • Ingwersen, F.: The pharmacokinetics of 3H-digitoxin and its metabolites in the guinea-pig. Naunyn-Schmiedebergs Arch. Pharmacol. 282 (Suppl. R): 38 (1974)

    Google Scholar 

  • Izumi, T., Fujino, S., Yorozuya, S., Tanaka, M.: Accumulation of digitoxin by the heart and “the cumulative effect of digitalis.” Jap. J. Pharmacol. 18, 269–270 (1968)

    CAS  Google Scholar 

  • Katzung, B.G., Meyers, F.H.: Excretion of radioactive digitoxin by the dog. J. Pharmacol. Exp. Ther. 149, 257–262 (1965)

    PubMed  CAS  Google Scholar 

  • Katzung, B.G., Meyers, F.H.: Biotransformation of digitoxin in the dog. J. Pharmacol. Exp. Ther. 154, 575–580 (1966)

    PubMed  CAS  Google Scholar 

  • Klaassen, C.D.: Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides. J. Pharmacol. Exp. Ther. 191, 201–211 (1974)

    PubMed  CAS  Google Scholar 

  • Kokenge, F., Jost, S., Kolenda, K.-D.: Vergleichende Untersuchung über die Serumspiegel von Digoxin und Digitoxin bei eingeschränkter Nierenfunktion. Therapiewoche 28, 1032–1036 (1978)

    Google Scholar 

  • Kolenda, K.-D., Ullmann, H., Peters, T.: Metabolism of cardiac glycosides studies in the isolated perfused guinea-pig liver. Brit. J. Pharmacol. 41, 661–673 (1971)

    CAS  Google Scholar 

  • Kramer, P., Horenkamp, J., Willms, B., Scheler, F.: Das Kumulationsverhalten verschiedener Herzglykoside bei Anurie. Dtsch. Med. Wochenschr. 95, 444–454 (1970)

    PubMed  CAS  Google Scholar 

  • Kramer, P.: Digitalis pharmacokinetics and therapy with respect to impaired renal function. Klin. Wochenschr. 55, 1–11 (1977)

    PubMed  Google Scholar 

  • Krasula, R.W., Hastreiter, A.R., Levitsky, S., Yanagi, R., Soyka, L.F.: Serum, atrial, and urinary digoxin levels during cardiopulmonary bypass in children. Circulation 49, 1047–1052 (1974)

    PubMed  CAS  Google Scholar 

  • Kuhlmann, J., Abshagen, U., Rietbrock, N.: Cleavage of glycoside bonds of digoxin derivatives as function of pH and time. Naunyn-Schmiedebergs Arch. Pharmacol. 276, 149–256 (1973)

    CAS  Google Scholar 

  • Kuhlmann, J., Abshagen, U., Rietbrock, N.: Pharmacokinetics and metabolism of digitoxigenin-mono-digitoxoside in man. Eur. J. Clin. Pharmacol. 7, 87–94 (1974)

    PubMed  CAS  Google Scholar 

  • Kuhlmann, J., Rietbrock, N., Schnieders, B.: Tissue distribution of cardiac glycosides. In: Cardiac glycosides. International Boehringer Mannheim Symposia. Bodem, G., Dengler, H.J. (eds.), part 1, pp. 109–119. Berlin, Heidelberg, New York: Springer 1978

    Google Scholar 

  • Lahrtz, H.G., Reinold, H.M., Zwieten, P.A., van: Serum-Konzentration und Ausscheidung von 3H-Digitoxin beim Menschen unter normalen und pathologischen Bedingungen. Klin. Wochenschr. 47, 695–700 (1969)

    PubMed  CAS  Google Scholar 

  • Larsen, A., Storstein, L.: Protein binding and pharmacokinetics of digitoxin in children. VIII World Congress of Cardiology, Tokyo, September 1978. Abstracts-I, p. 419. Ciba-Geigy Ltd., Basel

    Google Scholar 

  • Lauterbach, F.: Enterale Resorption, biliäre Ausscheidung und enterohepatischer Kreislauf von Herzglykosiden bei der Ratte. Naunyn-Schmiedebergs Arch. Pharmacol. 247, 391–411 (1964)

    CAS  Google Scholar 

  • Lauterbach, F., Repke, K.: Über die Verteilung herzglykosidspaltender Fermente im tieri- schen Organismus. Naunyn-Schmiedebergs Arch. Pharmacol. 240, 45–71 (1969)

    Google Scholar 

  • Lawrence, J.R., Sumner, D.J., Kalk, W.J., Ratcliffe, W.A., Whiting, B., Gray, K., Lindsay, M.: Digoxin kinetics in patients with thyroid dysfunction. Clin. Pharmacol. Ther. 22, 7–14 (1977)

    PubMed  CAS  Google Scholar 

  • Lukas, D.S.: Some aspects of the distribution and disposition of digitoxin in man. Ann. N.Y. Acad. Sci. 179, 338–362 (1971)

    PubMed  CAS  Google Scholar 

  • Lukas, D.S.: Pharmacokinetics and metabolism of digitoxin in man. In: Symposium on digitalis. Storstein, O. (ed.), pp. 84–102. Oslo: Gyldendal Norsk Forlag 1973

    Google Scholar 

  • Lukas, D.S., Peterson, R.E.: Double isotope dilution derivative assay of digitoxin in plasma, urine, and stools of patients maintained on the drug. J. Clin. Invest. 45, 782–796 (1966)

    PubMed  CAS  Google Scholar 

  • Lüllmann, H., Peters, T., Zwieten, P.A. van: The distribution of 3H-labeled cardenolides between isolated guinea-pig atrial tissue and circulating, oxygenated whole blood. Brit. J. Pharmacol. 36, 276–285 (1969)

    Google Scholar 

  • Marzo, A., Ghirardi, P., Prett, A., Lombardo, A., Longhini, C., Musacci, G.: Subcellular distribution of deslanatoside C, ouabain, and digitoxin in the heart and liver of conscious guinea pigs. Biochem. Pharmacol. 26, 2427–2431 (1977)

    PubMed  CAS  Google Scholar 

  • Morrison, J., Killip, T.: Radioimmunoassay of digitoxin. Clin. Res. 18, 668 (1970)

    Google Scholar 

  • Myhre, E., Storstein, L., Amlie, J.P.: Studies on digitalis. 16. Malabsorption of digitoxin in severely symptomatic patients with sprue and dumping syndrome after gastrectomy. Submitted for publication Nativelle, C.A.: Sur la digitaline cristallisée. J. Pharm. (Lond.) 9, 255 (1864)

    Google Scholar 

  • Okita, G.T.: Studies with radioactive digitalis. J. Am. Geriatr. Soc. 5, 163–175 (1957)

    PubMed  CAS  Google Scholar 

  • Okita, G.T.: Species difference in duration of action of cardiac glycosides. Fed. Proc. 26, 1125–1130 (1967)

    PubMed  CAS  Google Scholar 

  • Okita, G.T., Kelsey, F.E., Talso, P.J., Smith, L.B., Geiling, E.M.K.: Studies on the renal excretion of radioactive digitoxin in human subjects with cardiac failure. Circulation 7, 161–168 (1953)

    PubMed  CAS  Google Scholar 

  • Okita, G.T., Plotz, E.J., Davis, M.E.: Placental transfer of radioactive digitoxin in pregnant women and its fetal distribution. Circulation 9, 376–380 (1956)

    Google Scholar 

  • Okita, G.T., Talso, P.J., Curry, J.H., Smith, F.D., Geiling, E.M.K.: Blood level studies of 14C-digitoxin in human subjects with cardiac failure. J. Pharmacol. Exp. Ther. 113, 376–383 (1955a)

    PubMed  CAS  Google Scholar 

  • Okita, G.T., Talso, P.J., Curry, J.C., Smith, F.D., Geiling, E.M.K.: Metabolic fate of radio- active digitoxin in human subjects. J. Pharmacol. Exp. Ther. 115, 371–379 (1955b)

    PubMed  CAS  Google Scholar 

  • Oliver, G.Ch., Santinin, L.A., Griffin, G., Ruffy, R.: Enterohepatic circulation of digitoxin metabolites in the dog. In: Cardiac glycosides. Internation. Boehringer Mannheim Symposia, Bodem, G., Dengler, H.J. (eds.), part 1, pp. 85–93. Berlin, Heidelberg, New York: Springer 1978

    Google Scholar 

  • Peters, U., Hausamen, T.-U., Grosse-Brockhoff, F.: Therapie mit Digitoxin unter Kontrolle des Serum-Digitoxinspiegels. Dtsch. Med. Wochenschr. 99, 1701–1701 (1974)

    PubMed  CAS  Google Scholar 

  • Peters, U., Grabensee, B., Hausamen, T.-U., Fritsch, W.P., Grosse-Brockhoff, F.: Pharmakokinetik von Digitoxin bei chronischer Niereninsuffizienz. Dtsch. Med. Wochenschr. 102, 109–115 (1977)

    PubMed  CAS  Google Scholar 

  • Rasmussen, K., Jervell, J., Storstein, L., Gjerdrum, K.: Digitoxin kinetics in patients with impaired renal function. Clin. Pharmacol. Ther. 13, 6–15 (1972)

    PubMed  CAS  Google Scholar 

  • Rasmussen, K., Jervell, J., Storstein, O.: Clinical use of bioassay of serum digitoxin activity. Eur. J. Pharmacol. 3, 236–252 (1971)

    CAS  Google Scholar 

  • Repke, K.: Verteilung, Ausscheidung und Stoffwechsel von Digitoxin bei der Ratte. Naunyn-Schmiedebergs Arch. Pharmacol. 233, 271–283 (1958)

    CAS  Google Scholar 

  • Repke, K.: Die Bis-und Mono-digitoxoside des Digitoxigenins und Digoxigenins. Metaboliten des Digitoxins. Naunyn-Schmiedebergs Arch. Pharmakol. 237, 155–170 (1959)

    CAS  Google Scholar 

  • Repke, K., Samuels, L.T.: Enzymatic basis for epimerization of cardiotonic steroids at carbon 3 in rat liver. Biochemistry 3, 689–695 (1964)

    PubMed  CAS  Google Scholar 

  • Rietbrock, N., Vöhringer, H.F.: Metabolism and excretion of 3H-digitoxin in the rat. Biochem. Pharmacol. 23, 2567–2575 (1974)

    PubMed  CAS  Google Scholar 

  • Shenfield, G.M., Thompson, J., Horn, D.B.: Plasma and urinary digoxin in thyroid dysfunction. Eur. J. Clin. Pharmacol. 12, 437–443 (1977)

    PubMed  CAS  Google Scholar 

  • Steiness, E., Valentin, N.: Myocardial digoxin uptake: Dissociation between digitalis-induced inotropism and myocardial loss of potassium. Brit. J. Pharmacol. 58, 183–188 (1976)

    CAS  Google Scholar 

  • Stoll, R.G., Christensen, M.S., Sakmar, E., Blair, D., Wagner, J.G.: Determination of bio-availability of digitoxin using the radioimmunoassay procedure. J. Pharm. Sci. 62, 1615–1620 (1973)

    PubMed  CAS  Google Scholar 

  • Storstein, L.: The influence of renal function on the pharmacokinetics of digitoxin. In: Symposium on digitalis. Storstein, O. (ed.), pp. 158–168. Oslo: Gyldendal Norsk Forlag 1973

    Google Scholar 

  • Storstein, L.: Studies on digitalis. I. Renal excretion of digitoxin and its cardioactive metabolites. Clin. Pharmacol. Ther. 16, 14–24 (1974a)

    PubMed  CAS  Google Scholar 

  • Storstein, L.: Studies on digitalis. II. The influence of impaired renal function on the renal excretion of digitoxin and its cardioactive metabolites. Clin. Pharmacol. Ther. 16, 25–34 (1974b)

    PubMed  CAS  Google Scholar 

  • Storstein, L.: Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digi- toxin and its cardioactive metabolites. Clin. Pharmacol. Ther. 17, 313–320 (1975)

    PubMed  CAS  Google Scholar 

  • Storstein, L.: Studies on digitalis. V. The influence of impaired renal function, hemodialysis, and drug interaction on serum protein binding of digitoxin and digoxin. Clin. Pharmacol. Ther. 20, 6–14 (1976a)

    PubMed  CAS  Google Scholar 

  • Storstein, L.: Studies on digitalis. VII. The influence of nephrotic syndrome on protein binding, pharmacokinetics, and renal excretion of digitoxin and cardioactive metabolites. Clin. Pharmacol. Ther. 20, 158–166 (1976b)

    PubMed  CAS  Google Scholar 

  • Storstein, L.: Studies on digitalis. VIII. Digitoxin metabolism on a maintenance regimen and after a single dose. Clin. Pharmacol. Ther. 21, 125–140 (1977a)

    PubMed  CAS  Google Scholar 

  • Storstein, L.: Studies on digitalis. X. Digitoxin metabolites in human myocardium and relationship between myocardial and serum concentrations of digitoxin in patients on maintenance treatment. Clin. Pharmacol. Ther. 21, 395–408 (1977b)

    PubMed  CAS  Google Scholar 

  • Storstein, L.: Studies on digitalis. XI. Digitoxin metabolism in patients with impaired renal function. Clin. Pharmacol. Ther. 21, 536–546 (1977c)

    PubMed  CAS  Google Scholar 

  • Storstein, L., Amlie, J.P.: Studies on digitalis. IX. Some kinetic aspects of digitoxin metabolism. Clin. Pharmacol. Ther. 21, 255–266 (1977a)

    PubMed  CAS  Google Scholar 

  • Storstein, L., Amlie, J.P.: Studies on digitalis. XII. Kinetic pattern of digitoxin metabolism in patients with biliary fistulas. Clin. Pharmacol. Ther. 21,659–674 (1977b)

    PubMed  CAS  Google Scholar 

  • Storstein, L.: Digitoksin i klinisk bruk. T. norske Legeforen. Hjerte-Karsykdommer i praksis 22, 23–30 (1979a)

    Google Scholar 

  • Storstein, L., Amlie, J.P.: Pharmacokinetics and metabolism in patients with chronic active hepatitis. In: Digitoxin als Alternative in der Therapie der Herzinsuffizienz. Rietbrock, N., Greeff, K. (eds.), pp. 191–199. Frankfurt, 1978. München: Schattauer 1979

    Google Scholar 

  • Storstein, L., Jonsgard, M.: Studies on digitalis. 15. Bioavailability of digitoxin. Acta Med. Scand. Suppl. 645, 91–95 (1981)

    CAS  Google Scholar 

  • Storstein, L., Nore, A.-K., Sjaastad, O.: Studies on digitalis. 23. Blood-brain barrier of digitoxin in humans. Clin. Cardiol. 2, 146–150 (1979)

    PubMed  CAS  Google Scholar 

  • Storstein, L.: Why thyrotoxic patients need increased doses of digitoxin. Suppl. Circulation. 60-II-182 (1979)

    Google Scholar 

  • Storstein, L., Larsen, A., Midtbö, K.: Is old age a risk factor for digitoxin intoxication? VIII European Congress of Cardiology, Paris, June 1980, p. 204, published by Sandoz, Basel

    Google Scholar 

  • Storstein, O., Hansteen, V., Hatle, L., Hillestad, L., Storstein, L.: Studies on digitalis. XIII. A prospective study of 649 patients on maintenance treatment with digitoxin. Am. Heart J. 93, 434–443 (1977)

    PubMed  CAS  Google Scholar 

  • Takanashi, T., Katoh, T., Takeda, H., Tokuoka, T., Hamamoto, H., Kitamura, K.: The absorption of digitoxin in patients with acute and chronic diarrhea. Jpn. Circ. J. 42, 849–853 (1978)

    PubMed  CAS  Google Scholar 

  • Vöhringer, H.F., Rietbrock, N.: Metabolism and excretion of digitoxin in man. Clin. Pharmacol. Ther. 16, 796–806 (1974)

    PubMed  Google Scholar 

  • Vöhringer, H.F., Rietbrock, N., Spurny, P., Kuhlmann, J, Hampl, H., Baethke, R.: Disposition of digitoxin in renal failure. Clin. Pharmacol. Ther. 19, 387–395 (1976)

    PubMed  Google Scholar 

  • Vöhringer, H.F., Weller, L., Rietbrock, N.: Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxin in rats. Naunyn-Schmiedebergs Arch. Pharmacol. 287, 129–139 (1975)

    Google Scholar 

  • Vöhringer, H.F., Wogenstein, J.-M., Rietbrock, N.: Die biologische Verfügbarkeit von Digitoxin. Fortschr. Med. 95, 2323–2325 (1977)

    PubMed  Google Scholar 

  • Wirth, K.E., Frölich, J.C., Hollefield, J.W., Falkner, F.C., Sweetman, B.S., Oates, J.A.: Metabolism of digitoxin in man and its modification by spironolactone. Eur. J. Clin. Pharmacol. 9, 345–3 54 (1976)

    Google Scholar 

  • Wright, S.E.: The metabolism of cardiac glycosides. Springfield, Ill.: Charles C. Thomas 1960

    Google Scholar 

  • Zilly, W., Frank, P., Richter, E., Rietbrock, N.: Die Elimination von Digitoxin bei Leberkrankheiten. Verh. Dtsch. Ges. Inn. Med. 82, 1663–1666 (1976)

    PubMed  Google Scholar 

Download references

Authors
  1. Liv Storstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Instituts für Pharmakologie, Universität Düsseldorf, Moorenstraße 5, D-4000, Düsseldorf, Deutschland

    Kurt Greeff (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Storstein, L. (1981). Pharmacokinetics of Digitoxin. In: Greeff, K. (eds) Cardiac Glycosides. Handbook of Experimental Pharmacology, vol 56 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68166-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68166-0_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-68168-4

  • Online ISBN: 978-3-642-68166-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation